# Outcomes4Me

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/outcomes4me

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.outcomes4me.com
- Total disclosed funding: $38M
- Latest round: Series A (May 29, 2025)
- Investors on record: 9

## About

Outcomes4Me Inc., based in Boston, US, provides a digital platform that empowers cancer patients through personalized treatment options via a mobile app and web interface, integrating advanced AI for informed healthcare decisions.Outcomes4Me Inc. focuses on supporting cancer patients with its digital solutions. Founded in 2017 in Boston, US, the company has successfully completed 4 deals, with the latest funding round in May 2025, raising USD 21.00 mn led by Salica Investments. The CEO and founder is Maya Said, who has a history of leading innovative ventures.Outcomes4Me offers a comprehensive digital platform designed to support cancer patients through a free mobile app and web interface. The core service provides users with personalized treatment options based on the NCCN Clinical Practice Guidelines in Oncology, integrating advanced Artificial Intelligence to translate complex medical information into easily understandable recommendations. This empowers users—primarily cancer patients and their caregivers—to engage more effectively with their healthcare teams and make informed decisions about their treatment pathways. Additionally, Outcomes4Me facilitates access to the best cancer care and resources, aiming to streamline patient access to clinical trials and research initiatives. The company serves a diverse clientele, including individual patients across the United States and prospective users in international markets where cancer treatment resources may be needed.Outcomes4Me generates revenue through strategic partnerships and collaborations with healthcare providers, research institutions, and pharmaceutical companies, enhancing patient access to effective cancer treatments and clinical trials. The business operates on a model that includes B2B and direct-to-consumer transactions, allowing healthcare organizations to integrate the app into their patient care offerings. By utilizing their platform, partners can leverage AI-driven treatment guidance, resulting in improved patient outcomes and resource management. While specific pricing plans and revenue structures remain undisclosed, the company’s focus on partnerships suggests that the revenue model is likely tied to subscription fees or service agreements with healthcare professionals and organizations utilizing their digital solutions for patient support and education.In May 2025, Outcomes4Me Inc. raised USD 21.00 mn in funding to accelerate market penetration across cancer types and geographies, expand AI capabilities, and enhance global collaborations. The company plans to launch new products designed to improve patient engagement and treatment accessibility. Future market expansions are being targeted towards regions identified as having high unmet needs in cancer care, with specific timelines yet to be finalized.

## Funding rounds

- Series A, May 29, 2025, $21M — Sierra Ventures, Asset Management Ventures, IRA Capital, Salica Investments, LabCorp Ventures, Northpond Ventures, Merstal Ltd., Forecast Fund
- Series A, Apr 15, 2021, $12M — Sierra Ventures, Asset Management Ventures, IRA Capital, Northpond Ventures, Merstal Ltd.
- Seed, Nov 18, 2020, $4.7M — Sierra Ventures, Asset Management Ventures, National Cancer Institute, Merstal Ltd.

## Investors

- Sierra Ventures (https://capitalatlas.ai/funds/sierra-ventures) — Seed, Series A
- Asset Management Ventures (https://capitalatlas.ai/funds/asset-management-ventures) — Seed, Series A
- National Cancer Institute — Seed
- Merstal Ltd. — Seed, Series A
- IRA Capital (https://capitalatlas.ai/funds/ira-capital) — Series A
- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Series A
- Salica Investments (https://capitalatlas.ai/funds/salica-investments) — Series A
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series A
- Forecast Fund (https://capitalatlas.ai/funds/forecast-fund) — Series A